Suchergebnisse - "Esnault, Vincent"

PubPharm (7)

1

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2023

von Teisseyre, M. | Brglez, V. | Cremoni, M. | +6

2

Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome

enthalten in: Journal of nephrology | 2022

von Meuleman, M. | Guilmin-Crépon, S. | Hummel, A. | +29

3

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy

enthalten in: Frontiers in immunology | 2022

von Teisseyre, M. | Cremoni, M. | Boyer-Suavet, S. | +5

4

Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients

enthalten in: EBioMedicine | 2021

von Massa, F. | Cremoni, M. | Gérard, A. | +17

5

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy

enthalten in: Frontiers in immunology | 2021

von Teisseyre, M. | Cremoni, M. | Boyer-Suavet, S. | +6

6

An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study)

enthalten in: Kidney international | 2018

von Rémy, P. | Audard, V. | Natella, P. | +61

7

Membranous nephropathy : Pathophysiology and natural history

enthalten in: Nephrologie & therapeutique | 2017

von Seitz-Polski, B. | Lambeau, G. | Esnault, V.

1
[1]